Funders · Entity Annotation Prototype (beta)

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: Iovance Biotherapeutics ×

Iovance Biotherapeutics

This funder is selected. Its supporting articles are shown below.

Iovance Biotherapeutics1

Articles mentioning Iovance Biotherapeutics

1 articles · page 1 of 1

598 Phase 2 trial of TIL therapy for metastatic uveal melanoma: evaluating cellular potency and tumor transcriptomic predictors of response

jitc · abstract · 2025-11-04 · 1 matching annotations

79.1%

Clinigen Limited Iovance Biotherapeutics Uveal melanoma cyclophosphamide fludarabine high-dose interleukin-2 Aldesleukin University of Pittsburgh adoptive cell therapy

…d improve outcomes.Acknowledgements Aldesleukin was provided by Clinigen Limited and Iovance Biotherapeutics.Trial Registration NCT03467516Refer…

Browse funders

Iovance Biotherapeutics

Articles mentioning Iovance Biotherapeutics

598 Phase 2 trial of TIL therapy for metastatic uveal melanoma: evaluating cellular potency and tumor transcriptomic predictors of response